APROGEN

Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for immunomodulation; Pharmaceutical preparations for immune-enhancing; Pharmaceutical preparations for intestinal health and for the prevention and treatment of respiratory diseases; Pharmaceutical preparations for digestive diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for treating intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Vaccines; Colostral antibodies for medical purposes; Antibody therapeutic preparations for medical purposes for the treatment of cancer; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; Anti-cancer preparations; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and compositions for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of auto-immune diseases